Advertisement
Screener

ACADIA PHARMACEUTICALS INC. (ACAD) Increase (Decrease) in Other Operating Liabilities

2.8 / 5 stars · 68/120 Roast Me

ACADIA PHARMACEUTICALS INC. Increase (Decrease) in Other Operating Liabilities

ACADIA PHARMACEUTICALS INC. (ACAD) reported Increase (Decrease) in Other Operating Liabilities of -$3.83 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInOtherOperatingLiabilities · last filed 2026-08-05

  • ACADIA PHARMACEUTICALS INC. increase (decrease) in other operating liabilities for the quarter ending 2026-06-30 was $2.67M, a 68.89% decline year-over-year.
  • ACADIA PHARMACEUTICALS INC. increase (decrease) in other operating liabilities for the quarter ending 2026-03-31 was -$6.50M, a 440.85% decline year-over-year.
  • ACADIA PHARMACEUTICALS INC. increase (decrease) in other operating liabilities for the quarter ending 2025-12-31 was $5.25M, a 91.95% increase year-over-year.
  • ACADIA PHARMACEUTICALS INC. increase (decrease) in other operating liabilities for the quarter ending 2025-09-30 was -$14.66M, a 595.24% decline year-over-year.
  • ACADIA PHARMACEUTICALS INC. increase (decrease) in other operating liabilities for fiscal 2025 was $1.08M, a 62.84% decline from fiscal 2024.
  • ACADIA PHARMACEUTICALS INC. increase (decrease) in other operating liabilities for fiscal 2024 was $2.91M, a 52.10% decline from fiscal 2023.
  • ACADIA PHARMACEUTICALS INC. increase (decrease) in other operating liabilities for fiscal 2023 was $6.07M, a 197.70% increase from fiscal 2022.
  • ACADIA PHARMACEUTICALS INC. increase (decrease) in other operating liabilities for fiscal 2022 was $2.04M, a 10.03% increase from fiscal 2021.
Period endIncrease (Decrease) in Other Operating Liabilities 3 monthIncrease (Decrease) in Other Operating Liabilities 6 monthIncrease (Decrease) in Other Operating Liabilities 9 monthIncrease (Decrease) in Other Operating Liabilities 12 month
2026-06-30$2.67M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05
-$3.83M
10-Q · filed 2026-08-05
$1.42M
derived: sum of 3 quarters · filed 2026-08-05
-$13.24M
derived: sum of 4 quarters · filed 2026-08-05
2026-03-31-$6.50M
10-Q · filed 2026-05-07
-$1.25M
derived: sum of 2 quarters · filed 2026-05-07
-$15.91M
derived: sum of 3 quarters · filed 2026-05-07
-$7.33M
derived: sum of 4 quarters · filed 2026-08-05
2025-12-31$5.25M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
-$9.41M
derived: sum of 2 quarters · filed 2026-02-26
-$826.00K
derived: sum of 3 quarters · filed 2026-08-05
$1.08M
10-K · filed 2026-02-26
2025-09-30-$14.66M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06
-$6.07M
derived: sum of 2 quarters · filed 2026-08-05
-$4.17M
10-Q · filed 2025-11-06
-$1.43M
derived: sum of 4 quarters · filed 2026-08-05
2025-06-30$8.59M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05
$10.49M
10-Q · filed 2026-08-05
$13.23M
derived: sum of 3 quarters · filed 2026-08-05
$16.19M
derived: sum of 4 quarters · filed 2026-08-05
2025-03-31$1.91M
10-Q · filed 2026-05-07
$4.64M
derived: sum of 2 quarters · filed 2026-05-07
$7.60M
derived: sum of 3 quarters · filed 2026-05-07
$8.69M
derived: sum of 4 quarters · filed 2026-05-07
2024-12-31$2.73M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$5.69M
derived: sum of 2 quarters · filed 2026-02-26
$6.78M
derived: sum of 3 quarters · filed 2026-02-26
$2.91M
10-K · filed 2026-02-26
2024-09-30$2.96M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06
$4.05M
derived: sum of 2 quarters · filed 2025-11-06
$175.00K
10-Q · filed 2025-11-06
$2.66M
derived: sum of 4 quarters · filed 2026-02-26
2024-06-30$1.09M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07
-$2.79M
10-Q · filed 2025-08-07
-$298.00K
derived: sum of 3 quarters · filed 2026-02-26
$3.11M
derived: sum of 4 quarters · filed 2026-02-26
2024-03-31-$3.87M
10-Q · filed 2025-05-08
-$1.39M
derived: sum of 2 quarters · filed 2026-02-26
$2.02M
derived: sum of 3 quarters · filed 2026-02-26
$5.97M
derived: sum of 4 quarters · filed 2026-02-26
2023-12-31$2.49M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$5.89M
derived: sum of 2 quarters · filed 2026-02-26
$9.84M
derived: sum of 3 quarters · filed 2026-02-26
$6.07M
10-K · filed 2026-02-26
2023-09-30$3.40M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07
$7.36M
derived: sum of 2 quarters · filed 2024-11-07
$3.59M
10-Q · filed 2024-11-07
$6.19M
derived: sum of 4 quarters · filed 2025-02-27
2023-06-30$3.95M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07
$182.00K
10-Q · filed 2024-08-07
$2.79M
derived: sum of 3 quarters · filed 2025-02-27
$3.71M
derived: sum of 4 quarters · filed 2025-02-27
2023-03-31-$3.77M
10-Q · filed 2024-05-09
-$1.16M
derived: sum of 2 quarters · filed 2025-02-27
-$239.00K
derived: sum of 3 quarters · filed 2025-02-27
$932.00K
derived: sum of 4 quarters · filed 2025-02-27
2022-12-31$2.61M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27
$3.53M
derived: sum of 2 quarters · filed 2025-02-27
$4.70M
derived: sum of 3 quarters · filed 2025-02-27
$2.04M
10-K · filed 2025-02-27
2022-09-30$922.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03
$2.09M
derived: sum of 2 quarters · filed 2023-11-03
-$568.00K
10-Q · filed 2023-11-03
$1.64M
derived: sum of 4 quarters · filed 2024-02-28
2022-06-30$1.17M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03
-$1.49M
10-Q · filed 2023-08-03
$721.00K
derived: sum of 3 quarters · filed 2024-02-28
$415.00K
derived: sum of 4 quarters · filed 2024-02-28
2022-03-31-$2.66M
10-Q · filed 2023-05-08
-$450.00K
derived: sum of 2 quarters · filed 2024-02-28
-$756.00K
derived: sum of 3 quarters · filed 2024-02-28
$760.00K
derived: sum of 4 quarters · filed 2024-02-28
2021-12-31$2.21M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28
$1.91M
derived: sum of 2 quarters · filed 2024-02-28
$3.42M
derived: sum of 3 quarters · filed 2024-02-28
$1.85M
10-K · filed 2024-02-28
2021-09-30-$306.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03
$1.21M
derived: sum of 2 quarters · filed 2022-11-03
-$357.00K
10-Q · filed 2022-11-03
$1.23M
derived: sum of 4 quarters · filed 2023-02-28
2021-06-30$1.52M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09
-$51.00K
10-Q · filed 2022-08-09
$1.53M
derived: sum of 3 quarters · filed 2023-02-28
$584.00K
derived: sum of 4 quarters · filed 2023-02-28
2021-03-31-$1.57M
10-Q · filed 2022-05-05
$15.00K
derived: sum of 2 quarters · filed 2023-02-28
-$932.00K
derived: sum of 3 quarters · filed 2023-02-28
$376.00K
derived: sum of 4 quarters · filed 2023-02-28
2020-12-31$1.58M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28
$635.00K
derived: sum of 2 quarters · filed 2023-02-28
$1.94M
derived: sum of 3 quarters · filed 2023-02-28
$2.32M
10-K · filed 2023-02-28
2020-09-30-$947.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09
$361.00K
derived: sum of 2 quarters · filed 2021-11-09
$737.00K
10-Q · filed 2021-11-09
$1.42M
derived: sum of 4 quarters · filed 2022-03-01
2020-06-30$1.31M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05
$1.68M
10-Q · filed 2021-08-05
$2.37M
derived: sum of 3 quarters · filed 2022-03-01
$3.13M
derived: sum of 4 quarters · filed 2022-03-01
2020-03-31$376.00K
10-Q · filed 2021-05-06
$1.06M
derived: sum of 2 quarters · filed 2022-03-01
$1.82M
derived: sum of 3 quarters · filed 2022-03-01
$2.23M
derived: sum of 4 quarters · filed 2022-03-01
2019-12-31$687.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01
$1.45M
derived: sum of 2 quarters · filed 2022-03-01
$1.85M
derived: sum of 3 quarters · filed 2022-03-01
$1.50M
10-K · filed 2022-03-01
2019-09-30$761.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04
$1.16M
derived: sum of 2 quarters · filed 2020-11-04
$810.00K
10-Q · filed 2020-11-04
$1.16M
derived: sum of 4 quarters · filed 2021-02-25
2019-06-30$401.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06
$49.00K
10-Q · filed 2020-08-06
$398.00K
derived: sum of 3 quarters · filed 2021-02-25
$581.00K
derived: sum of 4 quarters · filed 2021-02-25
2019-03-31-$352.00K
10-Q · filed 2020-05-08
-$3.00K
derived: sum of 2 quarters · filed 2021-02-25
$180.00K
derived: sum of 3 quarters · filed 2021-02-25
$424.00K
derived: sum of 4 quarters · filed 2021-02-25
2018-12-31$349.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25
$532.00K
derived: sum of 2 quarters · filed 2021-02-25
$776.00K
derived: sum of 3 quarters · filed 2021-02-25
$1.37M
10-K · filed 2021-02-25
2018-09-30$183.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31
$427.00K
derived: sum of 2 quarters · filed 2019-10-31
$1.02M
10-Q · filed 2019-10-31
$964.00K
derived: sum of 4 quarters · filed 2020-02-27
2018-06-30$244.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01
$835.00K
10-Q · filed 2019-08-01
$781.00K
derived: sum of 3 quarters · filed 2020-02-27
$764.00K
derived: sum of 4 quarters · filed 2020-02-27
2018-03-31$591.00K
10-Q · filed 2019-05-02
$537.00K
derived: sum of 2 quarters · filed 2020-02-27
$520.00K
derived: sum of 3 quarters · filed 2020-02-27
$558.00K
derived: sum of 4 quarters · filed 2020-02-27
2017-12-31-$54.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27
-$71.00K
derived: sum of 2 quarters · filed 2020-02-27
-$33.00K
derived: sum of 3 quarters · filed 2020-02-27
$34.00K
10-K · filed 2020-02-27
2017-09-30-$17.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06
$21.00K
derived: sum of 2 quarters · filed 2018-11-06
$88.00K
10-Q · filed 2018-11-06
$68.00K
derived: sum of 4 quarters · filed 2019-02-27
2017-06-30$38.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08
$105.00K
10-Q · filed 2018-08-08
$85.00K
derived: sum of 3 quarters · filed 2019-02-27
$65.00K
derived: sum of 4 quarters · filed 2019-02-27
2017-03-31$67.00K
10-Q · filed 2018-05-04
$47.00K
derived: sum of 2 quarters · filed 2019-02-27
$27.00K
derived: sum of 3 quarters · filed 2019-02-27
$7.00K
derived: sum of 4 quarters · filed 2019-02-27
2016-12-31-$20.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27
-$40.00K
derived: sum of 2 quarters · filed 2019-02-27
-$60.00K
derived: sum of 3 quarters · filed 2019-02-27
-$75.00K
10-K · filed 2019-02-27
2016-09-30-$20.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07
-$40.00K
derived: sum of 2 quarters · filed 2017-11-07
-$55.00K
10-Q · filed 2017-11-07
-$62.00K
derived: sum of 4 quarters · filed 2018-02-27
2016-06-30-$20.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08
-$35.00K
10-Q · filed 2017-08-08
-$42.00K
derived: sum of 3 quarters · filed 2018-02-27
-$143.00K
derived: sum of 4 quarters · filed 2018-02-27
2016-03-31-$15.00K
10-Q · filed 2017-05-09
-$22.00K
derived: sum of 2 quarters · filed 2018-02-27
-$123.00K
derived: sum of 3 quarters · filed 2018-02-27
-$1.00K
derived: sum of 4 quarters · filed 2018-02-27
2015-12-31-$7.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27
-$108.00K
derived: sum of 2 quarters · filed 2018-02-27
$14.00K
derived: sum of 3 quarters · filed 2018-02-27
$97.00K
10-K · filed 2018-02-27
2015-09-30-$101.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07
$21.00K
derived: sum of 2 quarters · filed 2016-11-07
$104.00K
10-Q · filed 2016-11-07
$218.00K
derived: sum of 4 quarters · filed 2017-02-28
2015-06-30$122.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04
$205.00K
10-Q · filed 2016-08-04
$319.00K
derived: sum of 3 quarters · filed 2017-02-28
$322.00K
derived: sum of 4 quarters · filed 2017-02-28
2015-03-31$83.00K
10-Q · filed 2016-05-05
$197.00K
derived: sum of 2 quarters · filed 2017-02-28
$200.00K
derived: sum of 3 quarters · filed 2017-02-28
$205.00K
derived: sum of 4 quarters · filed 2017-02-28
2014-12-31$114.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28
$117.00K
derived: sum of 2 quarters · filed 2017-02-28
$122.00K
derived: sum of 3 quarters · filed 2017-02-28
$127.00K
10-K · filed 2017-02-28
2014-09-30$3.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05
$8.00K
derived: sum of 2 quarters · filed 2015-11-05
$13.00K
10-Q · filed 2015-11-05
$19.00K
derived: sum of 4 quarters · filed 2016-02-29
2014-06-30$5.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06
$10.00K
10-Q · filed 2015-08-06
$16.00K
derived: sum of 3 quarters · filed 2016-02-29
2014-03-31$5.00K
10-Q · filed 2015-05-07
$11.00K
derived: sum of 2 quarters · filed 2016-02-29
2013-12-31$6.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29
$8.00K
10-K · filed 2016-02-29
2013-09-30$2.00K
10-Q · filed 2014-11-10
2011-12-31-$24.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27
-$47.00K
derived: sum of 2 quarters · filed 2014-02-27
-$69.00K
derived: sum of 3 quarters · filed 2014-02-27
-$92.00K
10-K · filed 2014-02-27
2011-09-30-$23.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-05
-$45.00K
derived: sum of 2 quarters · filed 2012-11-05
-$68.00K
10-Q · filed 2012-11-05
-$89.00K
derived: sum of 4 quarters · filed 2013-03-12
2011-06-30-$22.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08
-$45.00K
10-Q · filed 2012-08-08
-$66.00K
derived: sum of 3 quarters · filed 2013-03-12
-$85.00K
derived: sum of 4 quarters · filed 2013-03-12
2011-03-31-$23.00K
10-Q · filed 2012-05-08
-$44.00K
derived: sum of 2 quarters · filed 2013-03-12
-$63.00K
derived: sum of 3 quarters · filed 2013-03-12
2010-12-31-$21.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-12
-$40.00K
derived: sum of 2 quarters · filed 2013-03-12
-$90.00K
10-K · filed 2013-03-12
2010-09-30-$19.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-09
-$69.00K
10-Q · filed 2011-11-09
2010-06-30-$50.00K
10-Q · filed 2011-08-10
2009-12-31-$22.00K
10-K · filed 2012-03-06

Similar stocks

Stock NameCountryMarket CapPE Ratio
AbCellera Biologics Inc. (ABCL)$3.879B-14.59
Xenon Pharmaceuticals Inc. (XENE)$3.684B-14.27
Organon & Co. (OGN)United States$3.603B17.03
IDEAYA Biosciences, Inc. (IDYA)United States$3.540B-20.52
Tango Therapeutics, Inc. (TNGX)United States$4.154B-42.53
Indivior Pharmaceuticals, Inc. (INDV)$4.250B14.09
Amylyx Pharmaceuticals, Inc. (AMLX)United States$3.361B-13.15
Viking Therapeutics, Inc. (VKTX)United States$4.287B-8.51
Enliven Therapeutics, Inc. (ELVN)United States$3.307B-35.07
Arcutis Biotherapeutics, Inc. (ARQT)United States$3.303B115.47